Aviir company logo

The profile is currenly unclaimed by the seller. All information is provided by CB Insights.

aviir.com

Aviir has not claimed their Profile.

1 of Aviir's competitors have claimed theirs

Here’s why one competitor wins customers.

Life Line Screening logo

We are very pleased to be partnering with Life Line Screening. MCM’s clients will have access to the very latest in health screening services. The addition of these services will give our nurses important information for the early identification of patients with chronic conditions. This allows us to make the most effective interventions for the better health of the member and, thereby, achieve maximum clinical and financial outcomes.

Work for Aviir?

Compete with Aviir?

Brief our analysts.

Get in front of tech buyers.

100% free.

No pay-to-play nonsense.

Work for Aviir?

Brief our analysts.

Get in front of tech buyers.

100% free.

No pay-to-play nonsense.

You May Also Like

G
Genera Biosystems

Genera Biosystems is a development phase company that designs, develops and produces and clinically effective human molecular diagnostics with a focus on women's health.

H
Helix Diagnostics

Helix Diagnostics LLC is pursuing development and commercialization of multiplexed DNA detection systems based on capillary electrophoresis.

M
MicroPhage

MicroPhage's mission is to be a worldwide pioneer in rapid bacterial diagnostics, in both bacterial identification and antibiotic susceptibility/resistance testing, through its bacteriophage-based amplification platform for immunoassay diagnostics.

I
Integrative Diagnostics

Integrative Diagnostics is a early cancer detection company founded by Leroy Hood.

3
3PrimiR

3PrimiR is researching how mutations in micro RNA molecules can be used in cancer diagnostics.

C
Columbia BioSystems

Columbia BioSystems Inc. is a company engaged in molecular Nano-diagnostics using Molecularly Imprinted Polymers (MIPs) for the rapid detection of pathogens such as Methicillin-resistant Staphylococcus aureus (MRSA) , Anthrax, HIV, and Trypanosomiasis (sleeping sickness). The company uses MIPs to bind to proteins and, upon binding, change color thereby signaling the presence of the bacteria, virus or parasite.

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.